New Zealand’s market edges up ahead of US inflation data

The S&P/NZX 50 index rose 95 points, or 0.8%, to 11,601.42. Turnover was $147.1 million.

Brad Gordon, an investment adviser at Hobson Wealth, said NZ’s market was waiting to see what was written in the US inflation data tea leaves and what it would show about the big macro and interest-rate picture that investors were concerned about.

“Depending on what this inflation number looks like, I suspect we're due for the weakest number in terms of inflation,” he told BusinessDesk. 

Cancer diagnostics firm Pacific Edge jumped 7.6% to 49.5 cents after the company announced that new clinical evidence showed significant improvements in the performance of its genomic diagnostic Cxbladder tests had been accepted for publication.